001     282573
005     20251218103443.0
024 7 _ |a 10.1002/glia.70107
|2 doi
024 7 _ |a pmid:41331743
|2 pmid
024 7 _ |a pmc:PMC12672973
|2 pmc
024 7 _ |a 0894-1491
|2 ISSN
024 7 _ |a 1098-1136
|2 ISSN
037 _ _ |a DZNE-2025-01333
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Tascio, Dario
|0 0009-0004-0755-4476
|b 0
245 _ _ |a AMPA Receptors in NG2 Glia Differently Affect Signal Transduction in the Hippocampus and Cerebellum.
260 _ _ |a Bognor Regis [u.a.]
|c 2026
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1764927641_11990
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Gray matter NG2 glia constitute a heterogeneous population of cells whose functions remain incompletely understood. In the hippocampus, Schaffer collaterals activate AMPA receptors (AMPARs) in NG2 glia, giving rise to small excitatory post-synaptic currents (EPSCs). Climbing fibers of the cerebellum also form synapses with NG2 glia, although producing much larger EPSCs. We aimed to identify mechanisms generating these regional differences in the efficacy of neuron-glia synapses. Combined patch-clamp and RT-PCR analyses allowed for determining structural and functional differences of AMPARs expressed by the glial cells. Comparing pharmacological and molecular data in both regions revealed stronger expression of Ca2+ permeable AMPARs in cerebellar NG2 glia. Different expression patterns were found both for AMPAR subunits and their auxiliary proteins. Moreover, experiments using the low-affinity AMPAR antagonist γ-DGG pointed towards higher synaptic glutamate concentrations at cerebellar synapses, likely due to multivesicular release, which contributed to enhanced synaptic efficacy. Finally, we examined short-term plasticity and showed that pre- and postsynaptic mechanisms contributed to paired-pulse depression at climbing fiber-NG2 glia synapses. Together, our data provide new insights into the molecular and functional specialization of NG2 glia and improve our understanding of the mechanisms underlying neuron-glia synaptic signaling, by highlighting how region-specific differences in AMPAR composition and presynaptic release properties shape this communication in the central nervous system.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a AMPA receptor
|2 Other
650 _ 7 |a NG2 glia
|2 Other
650 _ 7 |a cerebellum
|2 Other
650 _ 7 |a hippocampus
|2 Other
650 _ 7 |a patch clamp
|2 Other
650 _ 7 |a subunit composition
|2 Other
650 _ 7 |a Receptors, AMPA
|2 NLM Chemicals
650 _ 7 |a chondroitin sulfate proteoglycan 4
|2 NLM Chemicals
650 _ 7 |a Antigens
|2 NLM Chemicals
650 _ 7 |a Proteoglycans
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Cerebellum: cytology
|2 MeSH
650 _ 2 |a Cerebellum: metabolism
|2 MeSH
650 _ 2 |a Cerebellum: physiology
|2 MeSH
650 _ 2 |a Receptors, AMPA: metabolism
|2 MeSH
650 _ 2 |a Receptors, AMPA: genetics
|2 MeSH
650 _ 2 |a Neuroglia: metabolism
|2 MeSH
650 _ 2 |a Neuroglia: physiology
|2 MeSH
650 _ 2 |a Neuroglia: drug effects
|2 MeSH
650 _ 2 |a Hippocampus: cytology
|2 MeSH
650 _ 2 |a Hippocampus: metabolism
|2 MeSH
650 _ 2 |a Hippocampus: physiology
|2 MeSH
650 _ 2 |a Signal Transduction: physiology
|2 MeSH
650 _ 2 |a Signal Transduction: drug effects
|2 MeSH
650 _ 2 |a Excitatory Postsynaptic Potentials: physiology
|2 MeSH
650 _ 2 |a Excitatory Postsynaptic Potentials: drug effects
|2 MeSH
650 _ 2 |a Synapses: physiology
|2 MeSH
650 _ 2 |a Mice, Inbred C57BL
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Rats
|2 MeSH
650 _ 2 |a Patch-Clamp Techniques
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Antigens
|2 MeSH
650 _ 2 |a Proteoglycans
|2 MeSH
700 1 _ |a Gebril, Nehal
|b 1
700 1 _ |a Jabs, Ronald
|b 2
700 1 _ |a Henneberger, Christian
|0 P:(DE-2719)2811625
|b 3
|u dzne
700 1 _ |a Steinhäuser, Christian
|0 0000-0003-2579-8357
|b 4
700 1 _ |a Seifert, Gerald
|0 0000-0003-1249-9083
|b 5
773 _ _ |a 10.1002/glia.70107
|g Vol. 74, no. 2, p. e70107
|0 PERI:(DE-600)1474828-9
|n 2
|p e70107
|t Glia
|v 74
|y 2026
|x 0894-1491
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/282573/files/DZNE-2025-01333.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/282573/files/DZNE-2025-01333.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:282573
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2811625
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-06
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GLIA : 2022
|d 2025-01-06
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-06
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b GLIA : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
920 1 _ |0 I:(DE-2719)1013029
|k AG Henneberger
|l Synaptic and Glial Plasticity
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013029
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21